Takeda Pharmaceutical Co Ltd
TSE:4502
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Zumiez Inc
NASDAQ:ZUMZ
|
US |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
TE Connectivity Ltd
NYSE:TEL
|
CH |
|
DIRTT Environmental Solutions Ltd
TSX:DRT
|
CA |
Wall St Price Targets
Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 375.24 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
6 375.24
JPY
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 375.24 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
